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Alzheimer’s disease (AD) is neurodegenerative disease, which is characterized by
progressive cognitive decline. Characteristic symptoms are memory loss, change of
behaviour and personality. The pathological hallmarks of AD are senile plaques and
neurofibrillary tangles of hyperphosphorylated τ protein. Currently there is no causal
treatment, because the aetiology stays unexplained, despite of intensive research.
Nowadays, the hypothesis assumes that soluble form of amyloid-β (Aβ) is asso-
ciated with toxic effects inside the cells, among others in mitochondria. There are
many intracellular proteins, which interact with Aβ, such as amyloid binding alcohol
dehydrogenase (ABAD). Interaction Aβ-ABAD with consequent alteration of ABAD
function has been shown to cause mitochondrial dysfunction, consequently leading to
the cell death. Therefore, inhibition of Aβ-ABAD along with ABAD inhibition seems
as a potential pharmacological target.
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The aim of this thesis was to synthesize substituted benzothiazole ureas as poten-
tial modulators of ABAD and subsequently to test their inhibition ability. New com-
pounds are comprised of structure of frentizole, an immunosuppressive drug which
displayed some minor inhibition (IC50 = 200 µM). This benzothiazole urea is relati-
vely facile to modify, therefore there were synthesized several series of its analogues.
In the diploma thesis, 21 potential modulators of ABAD were synthesized. The
structure activity relationship was determined from obtained results. The inhibition
ability was determined in vitro against ABAD enzyme. The results were presented as
percentage of remaining activity of ABAD enzyme.
13 compounds exert inhibition ability, 8 substances increase effects of ABAD en-
zyme. Slightly better inhibiting ability was observed in compounds with methoxy
group at position C6 of benzo[d ]thiazole scaffold in contrast with chlorine and fluo-
rine at the same position. The inhibition activity of compounds with modifications
of benzene scaffold at position C3 by fluorine and C4 by hydroxy group has been
observed as the most satisfying, therefore, these compounds are suitable candidates
for further evaluation. One compound was able to inhibit ABAD more than 85 % in
comparison to the control.
On the other hand, compounds with modification of benzene scaffold at position
C2 methoxy group and at position C4 fluorine exert activating ability of ABAD. The
most potent activator of ABAD was able to activate the enzyme by more then 15 %.
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